" class="no-js "lang="en-US"> Appointments Archives - Medtech Alert
Wednesday, April 10, 2024

Sort by:

Date

Top Post

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

DEM BioPharma, an immune-oncology company developing therapies that target signals on cancer cells and myeloid […]

Mauna Kea Technologies Announces the Appointment of Côme de La Tour du Pin as its Chief Financial Officer

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) […]

DAMONA Pharmaceuticals Appoints John Reilly as Chief Executive Officer

DAMONA Pharmaceuticals, a preclinical biopharmaceutical company focused on the discovery and development of first-in-class small […]

Reata Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President, Chief Research & Development Officer

Reata Pharmaceuticals, a global biopharmaceutical company focused on developing and commercializing novel therapies for patients […]

Akumin Appoints President and Chief Operating Officer

Akumin, a national partner of choice for U.S. hospitals, health systems and physician groups, with […]

Genezen Announces the Appointment of Key Executive Leaders, Expanding Viral Vector Capabilities

Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO), today announced the […]

Sir Richard Roberts Elected to National Academy of Sciences

New England Biolabs (NEB®) has announced that Sir Richard Roberts, Nobel Prize winner and Chief […]

EpimAb Biotherapeutics Appoints Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer

EpimAb Biotherapeutics, a clinical-stage biotechnology company specializing in the development of bispecific antibodies, today announced […]

Amarna Therapeutics Announces Appointment of Dr. Henk Streefkerk as New CEO

Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare […]

XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer

XNK Therapeutics today announced the appointment of Hugo Petit as Chief Financial Officer (CFO) and […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more